Daclatasvir 60 Tablets

Product Details:

Drug Type Generic Drugs
Ingredients DACLATSVIR 60
Physical Form Tablets
Function Anti-Viral
Recommended For Chronic hepatitis C virus (HCV) infection
Dosage Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.
Suitable For Adults
Share Your Product:

68.27-75.01 USD ($)/Bottle

Get a Price/Quote

Request To Call Back Send Inquiry

Price And Quantity

Minimum Order Quantity 3 Bottle
Price 68.27-75.01 USD ($)/Bottle

Product Specifications

Suitable For Adults
Quantity 50 Unit
Recommended For Chronic hepatitis C virus (HCV) infection
Dosage Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.
Storage Instructions ROOM TEMP. 10 -30 C
Function Anti-Viral
Drug Type Generic Drugs
Ingredients DACLATSVIR 60
Physical Form Tablets

Trade Information

Payment Terms Cash in Advance (CID)
Supply Ability 50 Bottle Per Week
Delivery Time 3 Week
Packaging Details 1*28S/BOTT
Main Export Market(s) Australia Eastern Europe Central America Middle East South America Asia Western Europe North America Africa
Main Domestic Market All India

Product Description

Enter Buying Requirement Details

+ Add Attachment

Email Id

Mobile number

Please Wait...

Other Products in 'Pharmaceutical Tablets' category

AMOXAPINE TAB Function : Other Minimum Order Quantity : 5 Price : 13.6616.39 USD ($)/Box Drug Type : Generic Drugs Suitable For : Adults Storage Instructions : ROOM TEMP. 10 30 C Ingredients : AMOXAPINE Quantity : 100 Boxes Recommended For : DEPRESSION Physical Form : Tablets Dosage : Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.

Send Inquiry

Abiraterone Acetate 250mg Function : Cancer Treatment Minimum Order Quantity : 3 Price : 259.59273.26 USD ($)/Bottle Drug Type : Specific Drug Suitable For : Adults, Aged Person Storage Instructions : ROOM TEMP. 10 30 C Ingredients : ABIRATERONE 250 Quantity : 5 Boxes Physical Form : Tablets Dosage : Prostate Cancer Metastatic castrationresistant prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic castrationresistant prostate cancer (CRPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Yonsa Indicated in combination with methylprednisolone for the treatment of patients with metastatic CRPC 500 mg (four 125mg tablets) PO qDay in combination with methylprednisolone 4 mg PO BID Metastatic highrisk castrationsensitive prostate cancer Zytiga Indicated in combination with prednisone for patients with metastatic highrisk castrationsensitive prostate cancer (CSPC) 1000 mg (two 500mg tablets or four 250mg tablets) PO qDay with prednisone 5 mg PO q12hr Dosage Modifications Strong CYP3A4 inducers Coadministration with strong CYP3A4 inducers (eg, phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital): Avoid if possible; if strong CYP3A4 inducer must be administered, increase abiraterone dosage frequency of abiraterone Reduce dose back to the previous dose and frequency, if the concomitant strong CYP3A4 inducer is discontinued Yonsa Increase from 500 mg qDay to 500 mg BID Zytiga Increase from 1000 mg qDay to 1000 mg BID Hepatic impairment (Zytiga) Baseline LFTs Mild (ChildPugh A): No dosage adjustment necessary Moderate (ChildPugh B): Reduce starting dose to 250 mg PO qDay; monitor ALT, AST, and bilirubin prior to start of treatment, qWeek for the first month, q2Weeks for the following 2 months of treatment and monthly thereafter If elevations in ALT and/or AST >5x ULN or total bilirubin >3x ULN occur in patients with baseline moderate hepatic impairment, discontinue abiraterone and do not retreat patients Severe (ChildPugh C): Do not use Increased LFTs during treatment ALT and/or AST >5x ULN or total bilirubin >3x ULN: Interrupt treatment; reinitiate at reduced dose of 750 mg PO qDay following return of LFTs to baseline or to AST/ALT 2.5x ULN and total bilirubin 1.5x ULN For patients who resume treatment, monitor serum transaminases and bilirubin at least q2Weeks for 3 months, and then monthly thereafter If hepatotoxicity recurs at 750 mg/day, may restart at 500 mg/day (after LFTs decrease as above) If hepatoxicity recurs at reduced dose of 500 mg/day, discontinue treatment Permanently discontinue treatment for patients who develop a concurrent elevation of ALT >3x ULN and total bilirubin >2x ULN in the absence of biliary obstruction or other causes responsible for the concurrent elevation Hepatic impairment (Yonsa) Baseline Moderate (ChildPugh Class B): Reduce 125 mg PO qDay; monitor ALT, AST, and bilirubin prior to the start of treatment, every week for the first month, q2Weeks for the following 2 months of treatment and monthly thereafter If elevations in ALT and/or AST >5x ULN or total bilirubin >3x ULN occur in patients with baseline moderate hepatic impairment: Discontinue treatment and do not retreat patients with abiraterone Severe (ChildPugh Class C): Do not use Increased LFTs during treatment ALT and/or AST >5x ULN or total bilirubin >3x ULN): Interrupt treatment; restart at a reduced dose of 375 mg qDay following return of liver function tests to the patients baseline or to AST and ALT 2.5x ULN and total bilirubin 1.5x ULN For patients who resume treatment, monitor serum transaminases and bilirubin at least q2Weeks for 3 months, and then monthly thereafter If hepatotoxicity recurs on 375 mg/day, may be restart aeduced dose of 250 mg/day (after LFTs decrease as above) I

Send Inquiry

FEBUXOSTAT 80 Function : Other Minimum Order Quantity : 5 Price : 7.508.19 USD ($)/Box Drug Type : Generic Drugs Suitable For : Women, Adults, Aged Person Storage Instructions : ROOM TEMP. 10 30 C Ingredients : FEBUXOSTAT 80 Quantity : 50 Boxes Recommended For : GOUT Physical Form : Tablets

Send Inquiry

FLUVOXAMINE 50 Function : Other Minimum Order Quantity : 5 Price : 27.3331.43 USD ($)/Box Drug Type : Generic Drugs Suitable For : Adults Storage Instructions : ROOM TEMP. 10 30 C Ingredients : FLUVOXAMINE Quantity : 50 Boxes Recommended For : Depression,Obsessivecompulsive disorder Physical Form : Tablets

Send Inquiry

SEND INQUIRY CALL ME FREE